Content about Company Listing Change

November 8, 2012
Perrigo chief: Store brands big driver behind OTC growth, prepping launch of Mucinex equivalent

Business for OTC store brands is expected to boom in the coming year, Perrigo chairman and CEO Joseph Papa told analysts discussing the private-label manufacturer's first quarter results during a conference call Wednesday, even as the growth rate across the entire OTC category slows.

ALLEGAN. Mich. — Business for OTC store brands is expected to boom in the coming year, Perrigo chairman and CEO Joseph Papa told analysts discussing the private-label manufacturer's first-quarter results during a conference call Wednesday, even as the growth rate across the entire OTC category slows. "What we are seeing though, is the continued acceleration of store brand as being the reason why we're seeing the growth in our OTC category. For us to have a 9.4% growth in our OTC category, we think is a strong indication," Papa said. 

September 20, 2012
Alliance Boots acquires stake in Chinese wholesale market

Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million.

LONDON — Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million. On completion of the transaction, which is subject to various regulatory approvals, Alliance Boots will be the second largest shareholder in Nanjing Pharmaceutical with board and operational management representation.

September 7, 2012
Kraft Foods CEO outlines strategic growth priorities for Mondelez International

Speaking this week at the Barclays Capital Back-to-School Consumer Conference, Kraft Foods chairman and CEO Irene Rosenfeld outlined how the soon-to-debut global snacks company Mondelez International is "uniquely positioned to win in the marketplace."

BOSTON — Speaking this week at the Barclays Capital Back-to-School Consumer Conference, Kraft Foods chairman and CEO Irene Rosenfeld outlined how the soon-to-debut global snacks company Mondelez International is "uniquely positioned to win in the marketplace."

September 7, 2012
Kraft Foods outlines plans for North American grocery biz

The future North American grocery business of Kraft Foods will deliver steady and profitable top-line growth, consistent bottom-line growth and a superior dividend payout, according to the business's future executive team.

BOSTON — The future North American grocery business of Kraft Foods will deliver steady and profitable top-line growth, consistent bottom-line growth and a superior dividend payout, according to the business's future executive team.

June 29, 2012
Coty eyes up to $700M in IPO

Coty has filed to raise as much as $700 million in an initial public offering.

NEW YORK — Coty has filed to raise as much as $700 million in an initial public offering. The filing with the Securities and Exchange Commission comes about a month after the beauty company dropped its bid for Avon because of Avon’s “delay and unwillingness to engage in discussions.”

In the filing, Coty told the SEC that it intends to list the Class A common stock on either the NASDAQ or the New York Stock Exchange under the symbol “COTY.” Coty did not reveal how many shares it plans to sell or their expected price.

May 30, 2012
Schiff to change ticker symbol from WNI to SHF

Schiff Nutrition International is scheduled to change its NYSE ticker symbol and, effective June 11, the stock will begin trading under the symbol SHF.

SALT LAKE CITY — Schiff Nutrition International is scheduled to change its NYSE ticker symbol and, effective June 11, the stock will begin trading under the symbol SHF.

“We are focused on building premium brands and leading innovation in heart health, joint care, immune support, digestive health and other key nutritional supplement conditions," Schiff CEO Tarang Amin said. "We are excited to begin trading under a new ticker symbol NYSE: SHF that more closely reflects our company name.”

March 21, 2012
Teva to list shares on New York Stock Exchange

Israel-based Teva Pharmaceutical Industries is switching stock exchanges, the company said.

JERUSALEM — Israel-based Teva Pharmaceutical Industries is switching stock exchanges, the company said.

The world's largest generic drug manufacturer — and increasingly a player in branded and specialty drugs — announced Wednesday that it would transfer the listing of its shares from the Nasdaq to the New York Stock Exchange, with plans to start trading on the NYSE on May 30 under its current ticker symbol, "TEVA."

March 20, 2012
Taro shares to trade on NYSE

Taro Pharmaceutical Industries will list its shares on the New York Stock Exchange, the Israel-based generic drug maker said Monday.

HAWTHORNE, N.Y. — Taro Pharmaceutical Industries will list its shares on the New York Stock Exchange, the Israel-based generic drug maker said Monday.

Starting Thursday, shares of Taro will trade on the exchange under the ticker symbol "TARO" and will concurrently cease to trade on the over-the-counter Pink Sheet markets.

April 4, 2011
GNC underwriters exercise option to purchase additional shares

GNC Holdings on Monday announced, in connection with its previously announced initial public offering, the underwriters have exercised in full their option to purchase from the selling stockholders an additional 3.375 million shares of Class A common stock.

PITTSBURGH — GNC Holdings on Monday announced, in connection with its previously announced initial public offering, the underwriters have exercised in full their option to purchase from the selling stockholders an additional 3.375 million shares of Class A common stock.

September 30, 2010
The Carlyle Group completes NBTY acquisition

Global alternative asset manager The Carlyle Group and NBTY on Monday announced that Carlyle has...

May 2, 2010
MiddleBrook files for Ch. 11

The maker of a long-acting formulation of the antibiotic amoxicillin has filed for bankruptcy....